For the past few years, US lawmakers have considered legislation that would grant six additional months of market exclusivity for previously approved drugs that have been successfully tested and subsequently approved by the Food and Drug Administration
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/01/18/health-affairs-web-first-us-six-month-drug-market-exclusivity-extensions-could-yield-nearly-100-million/
Posted
Jan 18 2017, 01:03 PM
by
Health Affairs BlogHealth Affairs Blog